| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/23/2005 | CN1596945A Chinese herbal plant medicinal oil |
| 03/23/2005 | CN1596939A Chinese patent drug for treating heart brain blood vessel disease and its preparation method |
| 03/23/2005 | CN1596938A Traditional Chinese medicine slow-releasing medicine for treating cardiovascular disease and its preparation method |
| 03/23/2005 | CN1596933A Preparation for treating coronary heart disease and stenocardia and its preparation method |
| 03/23/2005 | CN1596923A Isatis root and leonurus extract and its medicinal composition and use |
| 03/23/2005 | CN1596920A Medicinal composition for treating cardiopathy and its preparation method and use |
| 03/23/2005 | CN1596917A Preparation method of compound red-rooted salvia micro pill |
| 03/23/2005 | CN1596909A Production method of disodium adenosine triphosphate magnesium chloride injection |
| 03/23/2005 | CN1596907A Use of bamboo leaf flavone in preparation of medicine or health-care food for preventing or treating thrombus disease or blood deficiency disease |
| 03/23/2005 | CN1596906A Drip pill containing erigeron breviscapus and its preparation method |
| 03/23/2005 | CN1596905A Erigeron breviscapus dispersion tablet |
| 03/23/2005 | CN1596902A Notoginseng total saponin intestine soluble type preparation |
| 03/23/2005 | CN1596896A Aminochlorodipin, irbesartan compound preparation |
| 03/23/2005 | CN1596891A Preparation method of captopril compounding chitin polysaccharide slow release micro ball |
| 03/23/2005 | CN1596885A Propyl gallate freeze-dried powder-injection and its preparation method |
| 03/23/2005 | CN1194090C Growth factor and genetic sequence for encoding same |
| 03/23/2005 | CN1194007C Separation, synthesis and application in medicine for P6A'S metabolic product |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/23/2005 | CN1193783C External used medicine against piles |
| 03/23/2005 | CN1193776C Medicine for treating congestive heart failure and its prepn |
| 03/23/2005 | CN1193767C Medicine formed form ganglioside and erigeron breviscapus extract and health-care product and their application |
| 03/23/2005 | CN1193757C Sustained release ranolazine formulations |
| 03/23/2005 | CN1193756C SGK2 and SGK3 used as diagnostic and therapeutic targets |
| 03/23/2005 | CN1193755C Fast disintegrated and stripped oral cilostazol tablt and its prepn process |
| 03/23/2005 | CN1193753C Ginkgo leaf extract and injection fluid containing same |
| 03/23/2005 | CN1193746C Substituted nitrobenzene derimative for medicine and other use |
| 03/22/2005 | US6870070 Hydrogenation, resoulution, alkylation, bromination, andcarboxamidation |
| 03/22/2005 | US6870055 Heterocyclic amides such as 3-dimethylaminomethyl-6-methoxy-2 -methyl-4-phenyl-2H-isoquinoline-1-one, used as antiarrhythmic agents |
| 03/22/2005 | US6870031 Haemopoietin receptor and genetic sequences encoding same |
| 03/22/2005 | US6869975 Linked biaryl compounds |
| 03/22/2005 | US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 03/22/2005 | US6869972 Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use |
| 03/22/2005 | US6869970 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents |
| 03/22/2005 | US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/22/2005 | US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine) |
| 03/22/2005 | US6869954 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869950 Such as 1-(2-chloro-4-(n-octyloxy)benzyl)-2-methyl-6-(1-pentane -sulfonylcarbamoyl)benzimidazole |
| 03/22/2005 | US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents |
| 03/22/2005 | US6869943 Sorbitol dehydrogenase inhibitors |
| 03/22/2005 | US6869941 Combination of drospirenone and an estrogen sulphamate for HRT |
| 03/22/2005 | US6869789 Heparinase III and uses thereof |
| 03/22/2005 | US6869621 Diet composition comprising raw foods and dietary fibers |
| 03/22/2005 | US6869605 Anticarcinogenic agents |
| 03/22/2005 | CA2330092C Benzimidazole compounds as orl1-receptor agonists |
| 03/22/2005 | CA2125189C Pyropheophorbides and their use in photodynamic therapy |
| 03/17/2005 | WO2005023782A1 Substituted fused pyrimidine-4(3h)-one compound |
| 03/17/2005 | WO2005023777A1 Ppar-activating compound and pharmaceutical composition containing same |
| 03/17/2005 | WO2005023769A1 Process for the preparation of amlodipine salts |
| 03/17/2005 | WO2005023292A1 Methods of treating restenosis |
| 03/17/2005 | WO2005023287A1 Skin ulcer preventive curative agent containing human recombinant hgf |
| 03/17/2005 | WO2005023272A1 Pharmaceutical compositions and methods for lowering blood pressure and pulse rate |
| 03/17/2005 | WO2005023246A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
| 03/17/2005 | WO2005023241A1 The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 03/17/2005 | WO2005023239A1 Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases |
| 03/17/2005 | WO2005023238A1 Erg channel openers for the treatment of hyperexcitability-related neuronal diseases |
| 03/17/2005 | WO2005023237A1 Erg channel openers for the treatment of cardiac arrhythmias |
| 03/17/2005 | WO2005023188A2 Compounds and methods |
| 03/17/2005 | WO2005014814A3 5’-and 3’-capped aptamers and uses therefor |
| 03/17/2005 | WO2004069262A8 Herbal composition comprising commiphora mukul, allium sativum and curcuma longa |
| 03/17/2005 | WO2004069165A3 Methods and compositions for the treatment of gastrointestinal disorders |
| 03/17/2005 | WO2004016761A3 Gene therapy for critical limb ischemia with wild type or mutant enos |
| 03/17/2005 | WO2003045918A8 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 03/17/2005 | WO2003039578A8 Treatment of congestive heart failure |
| 03/17/2005 | WO2003037887A8 Therapeutic isoquinoline compounds |
| 03/17/2005 | WO2002050028A8 Substituted benzoindoles as spla2 inhibitors |
| 03/17/2005 | US20050059810 Dibenzylamine compound and medicinal use thereof |
| 03/17/2005 | US20050059741 Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1 |
| 03/17/2005 | US20050059740 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example |
| 03/17/2005 | US20050059721 Nonsedating alpha-2 agonists |
| 03/17/2005 | US20050059720 Medicinal compositions for the prevention or treatment of cardiac failure |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | US20050059700 Reacting compunds such as 6-methyl-12-oxa-tricyclo[8.2.1.0]trideca-2,4,6-trien-11-ol with compounds such as 4-(2,6-dichloro-phenyl)-piperidine to produce (+-)-cis-1-methyl-7-[[4-(2,6-dichloro-phenyl)piperidin-1-yl)]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059683 A1 adenosine receptor antagonists |
| 03/17/2005 | US20050059667 pH-dependent binder controls rate of dissolution of tablet; cardiovascular disease |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059657 Aminoisoxazole derivatives active as kinase inhibitors |
| 03/17/2005 | US20050059652 Open chain prolyl urea-related modulators of androgen receptor function |
| 03/17/2005 | US20050059618 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 03/17/2005 | US20050059616 administering flavonoids and optionally vitamin E or excipients for the prophylaxis of bone or cardiovascular disorders, headaches, hypertension, cancers, leukemia, arteriosclerosis, Alzheimer's disease, inflammatory diseases, rheumatic diseases, acne, alopecia or psoriasis |
| 03/17/2005 | US20050059609 New alpha crystalline form of perindopril tert-butylamine salt |
| 03/17/2005 | US20050059601 by administering an exendin peptide analog of given amino acid sequence; treating Type II diabetes, eating disorders, and insulin-resistance syndrome |
| 03/17/2005 | US20050059600 Chimeric natriuretic peptides |
| 03/17/2005 | US20050059108 Expression vector comprising nucleotide sequences coding neurotransmitter for use in prevention and treatment of obesity, anorexia, energy imbalance, diabetes, dyslipidemia, hypertension and/or insulin resistance |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells |
| 03/17/2005 | US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds |
| 03/17/2005 | US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 03/17/2005 | US20050058636 Medicament against thrombotic diseases |
| 03/17/2005 | US20050058633 Stem cells that transform to beating cardiomyocytes |
| 03/17/2005 | CA2537976A1 Ozonation products of cholesterol for the treatment and prevention of artherosclerosis and/or cardiovascular diseases |
| 03/17/2005 | CA2537829A1 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands |
| 03/17/2005 | CA2537746A1 Erg channel openers for the treatment of cardiac arrhythmias |
| 03/17/2005 | CA2537246A1 Skin ulcer preventive or curative agent containing human recombinant hgf |
| 03/17/2005 | CA2537097A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
| 03/17/2005 | CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/17/2005 | CA2532161A1 Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases |